Relationship between the transplacental gradients of bupivacaine and alpha 1‐acid glycoprotein.

MC Petersen, RG Moore, RL Nation, W. McMeniman

Research output: Contribution to journalArticleResearchpeer-review

Abstract

1 The binding of bupivacaine (400 ng/ml) to isolated alpha 1‐acid glycoprotein was studied at two protein concentrations. At 20 mg/100 ml the extent of bupivacaine binding was 31.0 +/‐ 1.8% (mean +/‐ s.d., n = 4), and at a protein concentration of 60 mg/100 ml binding of bupivacaine was 85.8 +/‐ 1.5% (n = 4). 2 Bupivacaine and alpha 1‐acid glycoprotein concentrations were measured in plasma samples collected from a maternal peripheral vein and the umbilical vein at delivery (n = 23). The ratio of the foetal:maternal bupivacaine concentrations ranged from 0.17 to 0.52, while the foetal:maternal ration for alpha 1‐acid glycoprotein concentrations ranged from 0.20 to 0.96. A positive relationship emerged between the two ratios (P less than 0.01). 3 The alpha 1‐acid glycoprotein concentration gradient across the placenta, and interindividual variability in the gradient appear to contribute to the low and variable transplacental bupivacaine concentration ratio observed. 1981 The British Pharmacological Society

Original languageEnglish
Pages (from-to)859-862
Number of pages4
JournalBritish Journal of Clinical Pharmacology
Volume12
Issue number6
DOIs
Publication statusPublished - 1 Jan 1981

Cite this

@article{ccaf5e101f0b44c8bcb2f1a67b2e1aee,
title = "Relationship between the transplacental gradients of bupivacaine and alpha 1‐acid glycoprotein.",
abstract = "1 The binding of bupivacaine (400 ng/ml) to isolated alpha 1‐acid glycoprotein was studied at two protein concentrations. At 20 mg/100 ml the extent of bupivacaine binding was 31.0 +/‐ 1.8{\%} (mean +/‐ s.d., n = 4), and at a protein concentration of 60 mg/100 ml binding of bupivacaine was 85.8 +/‐ 1.5{\%} (n = 4). 2 Bupivacaine and alpha 1‐acid glycoprotein concentrations were measured in plasma samples collected from a maternal peripheral vein and the umbilical vein at delivery (n = 23). The ratio of the foetal:maternal bupivacaine concentrations ranged from 0.17 to 0.52, while the foetal:maternal ration for alpha 1‐acid glycoprotein concentrations ranged from 0.20 to 0.96. A positive relationship emerged between the two ratios (P less than 0.01). 3 The alpha 1‐acid glycoprotein concentration gradient across the placenta, and interindividual variability in the gradient appear to contribute to the low and variable transplacental bupivacaine concentration ratio observed. 1981 The British Pharmacological Society",
author = "MC Petersen and RG Moore and RL Nation and W. McMeniman",
year = "1981",
month = "1",
day = "1",
doi = "10.1111/j.1365-2125.1981.tb01321.x",
language = "English",
volume = "12",
pages = "859--862",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "6",

}

Relationship between the transplacental gradients of bupivacaine and alpha 1‐acid glycoprotein. / Petersen, MC; Moore, RG; Nation, RL; McMeniman, W.

In: British Journal of Clinical Pharmacology, Vol. 12, No. 6, 01.01.1981, p. 859-862.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Relationship between the transplacental gradients of bupivacaine and alpha 1‐acid glycoprotein.

AU - Petersen, MC

AU - Moore, RG

AU - Nation, RL

AU - McMeniman, W.

PY - 1981/1/1

Y1 - 1981/1/1

N2 - 1 The binding of bupivacaine (400 ng/ml) to isolated alpha 1‐acid glycoprotein was studied at two protein concentrations. At 20 mg/100 ml the extent of bupivacaine binding was 31.0 +/‐ 1.8% (mean +/‐ s.d., n = 4), and at a protein concentration of 60 mg/100 ml binding of bupivacaine was 85.8 +/‐ 1.5% (n = 4). 2 Bupivacaine and alpha 1‐acid glycoprotein concentrations were measured in plasma samples collected from a maternal peripheral vein and the umbilical vein at delivery (n = 23). The ratio of the foetal:maternal bupivacaine concentrations ranged from 0.17 to 0.52, while the foetal:maternal ration for alpha 1‐acid glycoprotein concentrations ranged from 0.20 to 0.96. A positive relationship emerged between the two ratios (P less than 0.01). 3 The alpha 1‐acid glycoprotein concentration gradient across the placenta, and interindividual variability in the gradient appear to contribute to the low and variable transplacental bupivacaine concentration ratio observed. 1981 The British Pharmacological Society

AB - 1 The binding of bupivacaine (400 ng/ml) to isolated alpha 1‐acid glycoprotein was studied at two protein concentrations. At 20 mg/100 ml the extent of bupivacaine binding was 31.0 +/‐ 1.8% (mean +/‐ s.d., n = 4), and at a protein concentration of 60 mg/100 ml binding of bupivacaine was 85.8 +/‐ 1.5% (n = 4). 2 Bupivacaine and alpha 1‐acid glycoprotein concentrations were measured in plasma samples collected from a maternal peripheral vein and the umbilical vein at delivery (n = 23). The ratio of the foetal:maternal bupivacaine concentrations ranged from 0.17 to 0.52, while the foetal:maternal ration for alpha 1‐acid glycoprotein concentrations ranged from 0.20 to 0.96. A positive relationship emerged between the two ratios (P less than 0.01). 3 The alpha 1‐acid glycoprotein concentration gradient across the placenta, and interindividual variability in the gradient appear to contribute to the low and variable transplacental bupivacaine concentration ratio observed. 1981 The British Pharmacological Society

UR - http://www.scopus.com/inward/record.url?scp=0019774435&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.1981.tb01321.x

DO - 10.1111/j.1365-2125.1981.tb01321.x

M3 - Article

VL - 12

SP - 859

EP - 862

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 6

ER -